Caused by chronic GERD, Barrett’s esophagus is a precancerous condition affecting the lining of the esophagus. Currently, there is no adequate treatment option. Barrett’s affects about two million U.S. adults. Left untreated, Barrett’s esophagus can lead to esophageal adenocarcinoma, which is currently the most rapidly rising cancer in the U.S. 

The ablation procedure highlighted in the studies may be an alternative to “watchful waiting” for patients who due to chronic GERD have low-grade dysplasia (LGD) or high-grade dysplasia (HGD) and whose disease has not yet advanced to the point where surgery is required. During the procedure, the diseased tissue is removed allowing the regrowth of normal cells.

The ablation procedure provides for ablation of Barrett’s esophagus tissue with precise depth control. The non-surgical procedure is performed in an outpatient setting under conscious sedation. It is well tolerated by patients and is effective in removing their Barrett’s.

For those patients who are appropriate candidates for the ablation procedure, there is a high likelihood of completely removing this premalignant condition from their esophagus.  It may eventually reduce or eliminate the need for the surveillance endoscopy visits that are part of their current treatment plan. It may also reduce the chances of their Barrett’s esophagus progressing to a more serious stage. Having the procedure is likely to reduce the risk of progression to a more advanced disease state and reduce patient anxiety as it relates to “living with a premalignant condition."

Depending upon the procedure recommended and chosen for your condition, Tri-Cities Gastroenterology will treat you at the Center for Digestive Wellness or at a regional hospital.

Read about two types of procedures in these PDFs:

Halo 90
Halo 360

Or view videos / animations regarding these procedures by clicking here.